{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:33:45Z","timestamp":1785886425439,"version":"3.56.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13875-w","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T16:02:01Z","timestamp":1743782521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Causal association of breast cancer with immune cells: new evidence from bi-directional Mendelian randomization using GWAS summary statistics"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhixuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"issue":"3","key":"13875_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"13875_CR2","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.7150\/ijbs.21635","volume":"13","author":"YS Sun","year":"2017","unstructured":"Sun YS, et al. Risk factors and preventions of breast Cancer. Int J Biol Sci. 2017;13(11):1387\u201397.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"13875_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.32604\/oncologie.2022.027640","volume":"24","author":"C Shang","year":"2022","unstructured":"Shang C, Xu D. Epidemiology of breast Cancer. Oncologie. 2022;24(4):649\u201363.","journal-title":"Oncologie"},{"issue":"176","key":"13875_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.24976\/Discov.Med.202335176.29","volume":"35","author":"L Mingying","year":"2023","unstructured":"Mingying L, et al. Establishing a predictive model to predict survival of de Novo metastatic HER2-Low breast cancer: A National Cancer database analysis. Discov Med. 2023;35(176):283\u201392.","journal-title":"Discov Med"},{"issue":"1","key":"13875_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41416-020-01161-4","volume":"124","author":"AI Riggio","year":"2021","unstructured":"Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2021;124(1):13\u201326.","journal-title":"Br J Cancer"},{"issue":"7","key":"13875_CR6","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.32604\/biocell.2022.018023","volume":"46","author":"J LIU","year":"2022","unstructured":"Liu J, Pang K, He F. Weighted gene co-expression network analysis identifies a novel immune-related gene signature and nomogram to predict the survival and immune infiltration status of breast cancer. BIOCELL. 2022;46(7):1661\u201373.","journal-title":"BIOCELL"},{"issue":"3","key":"13875_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.32604\/biocell.2022.017337","volume":"46","author":"L WANG","year":"2022","unstructured":"Wang L, et al. Identification of a three-gene signature in the triple-negative breast cancer. BIOCELL. 2022;46(3):595\u2013606.","journal-title":"BIOCELL"},{"key":"13875_CR8","doi-asserted-by":"publisher","first-page":"p9605439","DOI":"10.1155\/2022\/9605439","volume":"2022","author":"D Kashyap","year":"2022","unstructured":"Kashyap D, et al. Global increase in breast Cancer incidence: risk factors and preventive measures. Biomed Res Int. 2022;2022:p9605439.","journal-title":"Biomed Res Int"},{"key":"13875_CR9","doi-asserted-by":"crossref","unstructured":"Dieci MV, Miglietta F, Guarneri V. Immune infiltrates in breast cancer: recent updates and clinical implications. Cells, 2021. 10(2).","DOI":"10.3390\/cells10020223"},{"issue":"1","key":"13875_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12282-016-0698-z","volume":"24","author":"S Burugu","year":"2017","unstructured":"Burugu S, Asleh-Aburaya K, Nielsen TO. Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication. Breast Cancer. 2017;24(1):3\u201315.","journal-title":"Breast Cancer"},{"issue":"7","key":"13875_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1200\/JCO.18.01010","volume":"37","author":"S Loi","year":"2019","unstructured":"Loi S, et al. Tumor-Infiltrating lymphocytes and prognosis: A pooled individual patient analysis of Early-Stage Triple-Negative breast cancers. J Clin Oncol. 2019;37(7):559\u201369.","journal-title":"J Clin Oncol"},{"issue":"2","key":"13875_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014. Ann Oncol. 2015;26(2):259\u201371.","journal-title":"Ann Oncol"},{"issue":"1","key":"13875_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10549-017-4499-7","volume":"167","author":"RA Leon-Ferre","year":"2018","unstructured":"Leon-Ferre RA, et al. Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer. Breast Cancer Res Treat. 2018;167(1):89\u201399.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"13875_CR14","doi-asserted-by":"publisher","first-page":"e50946","DOI":"10.1371\/journal.pone.0050946","volume":"7","author":"QW Zhang","year":"2012","unstructured":"Zhang QW, et al. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS ONE. 2012;7(12):e50946.","journal-title":"PLoS ONE"},{"issue":"22","key":"13875_CR15","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1158\/1078-0432.CCR-04-0684","volume":"10","author":"I Treilleux","year":"2004","unstructured":"Treilleux I, et al. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res. 2004;10(22):7466\u201374.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"13875_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ijc.10915","volume":"104","author":"M Iwamoto","year":"2003","unstructured":"Iwamoto M, et al. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer. 2003;104(1):92\u20137.","journal-title":"Int J Cancer"},{"issue":"3","key":"13875_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/08830185.2020.1845670","volume":"40","author":"E Arianfar","year":"2021","unstructured":"Arianfar E, Shahgordi S, Memarian A. Natural killer cell defects in breast cancer: A key pathway for tumor evasion. Int Rev Immunol. 2021;40(3):197\u2013216.","journal-title":"Int Rev Immunol"},{"key":"13875_CR18","doi-asserted-by":"crossref","unstructured":"Folgueira MA et al. Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series. Biosci Rep, 2013. 33(6).","DOI":"10.1042\/BSR20130060"},{"issue":"7","key":"13875_CR19","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1161\/ATVBAHA.113.300168","volume":"33","author":"A Mantovani","year":"2013","unstructured":"Mantovani A, Locati M. Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions. Arterioscler Thromb Vasc Biol. 2013;33(7):1478\u201383.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3\u20134","key":"13875_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000430499","volume":"82","author":"SD Soysal","year":"2015","unstructured":"Soysal SD, Tzankov A, Muenst SE. Role of the tumor microenvironment in breast Cancer. Pathobiology. 2015;82(3\u20134):142\u201352.","journal-title":"Pathobiology"},{"issue":"12","key":"13875_CR21","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1158\/1078-0432.CCR-17-1323","volume":"24","author":"A Afghahi","year":"2018","unstructured":"Afghahi A, et al. Higher absolute lymphocyte counts predict lower mortality from Early-Stage Triple-Negative breast Cancer. Clin Cancer Res. 2018;24(12):2851\u20138.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"13875_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10549-020-06016-3","volume":"186","author":"E Xie","year":"2021","unstructured":"Xie E, et al. Relationship of Circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer. Breast Cancer Res Treat. 2021;186(2):561\u20138.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"13875_CR23","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1002\/jcp.26896","volume":"234","author":"E Safarzadeh","year":"2019","unstructured":"Safarzadeh E, et al. Circulating myeloid-derived suppressor cells: an independent prognostic factor in patients with breast cancer. J Cell Physiol. 2019;234(4):3515\u201325.","journal-title":"J Cell Physiol"},{"issue":"19","key":"13875_CR24","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian Randomization JAMA. 2017;318(19):1925\u20136.","journal-title":"Mendelian Randomization JAMA"},{"issue":"R1","key":"13875_CR25","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89\u201398.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"13875_CR26","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham J, et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet. 2015;47(12):1457\u201364.","journal-title":"Nat Genet"},{"issue":"4","key":"13875_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J Bowden","year":"2019","unstructured":"Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: A review. Res Synth Methods. 2019;10(4):486\u201396.","journal-title":"Res Synth Methods"},{"issue":"10","key":"13875_CR28","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orru","year":"2020","unstructured":"Orru V, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52(10):1036\u201345.","journal-title":"Nat Genet"},{"issue":"12","key":"13875_CR29","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.joca.2021.08.003","volume":"29","author":"XH Yu","year":"2021","unstructured":"Yu XH, et al. The causal role of gut microbiota in development of osteoarthritis. Osteoarthritis Cartilage. 2021;29(12):1741\u201350.","journal-title":"Osteoarthritis Cartilage"},{"issue":"7571","key":"13875_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"C Genomes Project","year":"2015","unstructured":"Genomes Project C, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68\u201374.","journal-title":"Nature"},{"issue":"1","key":"13875_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12916-019-1448-9","volume":"17","author":"P Zeng","year":"2019","unstructured":"Zeng P, et al. Causal association of type 2 diabetes with amyotrophic lateral sclerosis: new evidence from Mendelian randomization using GWAS summary statistics. BMC Med. 2019;17(1):225.","journal-title":"BMC Med"},{"issue":"6","key":"13875_CR32","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","volume":"46","author":"OO Yavorska","year":"2017","unstructured":"Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46(6):1734\u20139.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"13875_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377\u201389.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"13875_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.autrev.2018.02.001","volume":"17","author":"D Brandt","year":"2018","unstructured":"Brandt D, Hedrich CM. TCRalphabeta(+)CD3(+)CD4(-)CD8(-) (double negative) T cells in autoimmunity. Autoimmun Rev. 2018;17(4):422\u201330.","journal-title":"Autoimmun Rev"},{"key":"13875_CR35","doi-asserted-by":"publisher","first-page":"816005","DOI":"10.3389\/fimmu.2022.816005","volume":"13","author":"Z Wu","year":"2022","unstructured":"Wu Z, et al. CD3(+)CD4(-)CD8(-) (Double-Negative) T cells in inflammation, immune disorders and Cancer. Front Immunol. 2022;13:816005.","journal-title":"Front Immunol"},{"issue":"1","key":"13875_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13046-019-1126-y","volume":"38","author":"L Fang","year":"2019","unstructured":"Fang L, et al. Targeting late-stage non-small cell lung cancer with a combination of DNT cellular therapy and PD-1 checkpoint Blockade. J Exp Clin Cancer Res. 2019;38(1):123.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"13875_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jcmgh.2019.08.004","volume":"9","author":"D Di Blasi","year":"2020","unstructured":"Di Blasi D, et al. Unique T-Cell populations define Immune-Inflamed hepatocellular carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9(2):195\u2013218.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"13875_CR38","doi-asserted-by":"publisher","first-page":"e1252894","DOI":"10.1080\/2162402X.2016.1252894","volume":"6","author":"Z Liu","year":"2017","unstructured":"Liu Z, et al. Tumor-infiltrating lymphocytes (TILs) from patients with glioma. Oncoimmunology. 2017;6(2):e1252894.","journal-title":"Oncoimmunology"},{"key":"13875_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40425-016-0164-7","volume":"4","author":"M Hall","year":"2016","unstructured":"Hall M, et al. Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors. J Immunother Cancer. 2016;4:61.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"13875_CR40","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.4049\/jimmunol.172.3.1602","volume":"172","author":"RM Prins","year":"2004","unstructured":"Prins RM, et al. Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity. J Immunol. 2004;172(3):1602\u201311.","journal-title":"J Immunol"},{"issue":"1","key":"13875_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1158\/0008-5472.CAN-13-1672","volume":"74","author":"V Vallacchi","year":"2014","unstructured":"Vallacchi V, et al. Transcriptional profiling of melanoma Sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression. Cancer Res. 2014;74(1):130\u201340.","journal-title":"Cancer Res"},{"issue":"9","key":"13875_CR42","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/leu.2011.99","volume":"25","author":"S Merims","year":"2011","unstructured":"Merims S, et al. Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy. Leukemia. 2011;25(9):1415\u201322.","journal-title":"Leukemia"},{"issue":"1","key":"13875_CR43","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13046-018-0756-9","volume":"37","author":"B Chen","year":"2018","unstructured":"Chen B, et al. Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy. J Exp Clin Cancer Res. 2018;37(1):88.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"13875_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40425-019-0507-2","volume":"7","author":"J Yao","year":"2019","unstructured":"Yao J, et al. Human double negative T cells target lung cancer via ligand-dependent mechanisms that can be enhanced by IL-15. J Immunother Cancer. 2019;7(1):17.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"13875_CR45","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1182\/blood.2020009081","volume":"138","author":"JB Lee","year":"2021","unstructured":"Lee JB, et al. Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production. Blood. 2021;138(3):234\u201345.","journal-title":"Blood"},{"issue":"6","key":"13875_CR46","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.7150\/ijbs.70120","volume":"18","author":"YH Yang","year":"2022","unstructured":"Yang YH, et al. CAR-T cell therapy for breast cancer: from basic research to clinical application. Int J Biol Sci. 2022;18(6):2609\u201326.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"13875_CR47","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1158\/1078-0432.CCR-16-3001","volume":"24","author":"LA Emens","year":"2018","unstructured":"Emens LA. Breast Cancer immunotherapy: facts and hopes. Clin Cancer Res. 2018;24(3):511\u201320.","journal-title":"Clin Cancer Res"},{"key":"13875_CR48","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3389\/fimmu.2019.02107","volume":"10","author":"S Nesmond","year":"2019","unstructured":"Nesmond S, et al. Characteristic pattern of IL-17RA, IL-17RB, and IL-17RC in monocytes\/macrophages and mast cells from patients with bullous pemphigoid. Front Immunol. 2019;10:2107.","journal-title":"Front Immunol"},{"issue":"2","key":"13875_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.immuni.2021.12.016","volume":"55","author":"X Lin","year":"2022","unstructured":"Lin X, et al. IL-17RA-signaling in Lgr5(+) intestinal stem cells induces expression of transcription factor ATOH1 to promote secretory cell lineage commitment. Immunity. 2022;55(2):237\u2013e2538.","journal-title":"Immunity"},{"issue":"4","key":"13875_CR50","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/3877","volume":"20","author":"A Puel","year":"1998","unstructured":"Puel A, et al. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet. 1998;20(4):394\u20137.","journal-title":"Nat Genet"},{"issue":"12","key":"13875_CR51","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1182\/blood.2019000553","volume":"138","author":"A Silva","year":"2021","unstructured":"Silva A, et al. Overexpression of wild-type IL-7Ralpha promotes T-cell acute lymphoblastic leukemia\/lymphoma. Blood. 2021;138(12):1040\u201352.","journal-title":"Blood"},{"key":"13875_CR52","doi-asserted-by":"crossref","unstructured":"Wang C et al. The role of IL-7 and IL-7R in Cancer pathophysiology and immunotherapy. Int J Mol Sci, 2022. 23(18).","DOI":"10.3390\/ijms231810412"},{"key":"13875_CR53","doi-asserted-by":"publisher","first-page":"857289","DOI":"10.3389\/fphar.2022.857289","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, et al. IL7R is correlated with immune cell infiltration in the tumor microenvironment of lung adenocarcinoma. Front Pharmacol. 2022;13:857289.","journal-title":"Front Pharmacol"},{"key":"13875_CR54","doi-asserted-by":"publisher","first-page":"106756","DOI":"10.1016\/j.intimp.2020.106756","volume":"86","author":"Z Wang","year":"2020","unstructured":"Wang Z, et al. IL-7R gene variants are associated with breast cancer susceptibility in Chinese Han women. Int Immunopharmacol. 2020;86:106756.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"13875_CR55","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, et al. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775\u201387.","journal-title":"Cell"},{"key":"13875_CR56","doi-asserted-by":"publisher","first-page":"106087","DOI":"10.1016\/j.intimp.2019.106087","volume":"78","author":"V Hashemi","year":"2020","unstructured":"Hashemi V, et al. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target. Int Immunopharmacol. 2020;78:106087.","journal-title":"Int Immunopharmacol"},{"key":"13875_CR57","doi-asserted-by":"crossref","unstructured":"Nishikawa H, Koyama S. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies. J Immunother Cancer, 2021. 9(7).","DOI":"10.1136\/jitc-2021-002591"},{"issue":"11","key":"13875_CR58","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/intimm\/dxz036","volume":"31","author":"S Hirose","year":"2019","unstructured":"Hirose S, et al. Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis. Int Immunol. 2019;31(11):687\u201396.","journal-title":"Int Immunol"},{"issue":"1","key":"13875_CR59","doi-asserted-by":"publisher","first-page":"e12883","DOI":"10.1111\/sji.12883","volume":"92","author":"A Ozanska","year":"2020","unstructured":"Ozanska A, Szymczak D, Rybka J. Pattern of human monocyte subpopulations in health and disease. Scand J Immunol. 2020;92(1):e12883.","journal-title":"Scand J Immunol"},{"issue":"2","key":"13875_CR60","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/JLB.4RI0818-311R","volume":"106","author":"CE Olingy","year":"2019","unstructured":"Olingy CE, Dinh HQ, Hedrick CC. Monocyte heterogeneity and functions in cancer. J Leukoc Biol. 2019;106(2):309\u201322.","journal-title":"J Leukoc Biol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13875-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13875-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13875-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T22:15:48Z","timestamp":1743891348000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13875-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13875"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13875-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"9 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"609"}}